< Key Hightlight >

MARKET OUTLOOK

Triton’s research report insinuates that the Latin American infertility testing and treatment market is estimated to grow at a CAGR of 9.71% during the period 2021-2028. Mexico, Brazil, and Rest of Latin America shape the market in this region.

In Mexico, the growing number of clinically advanced fertility centers is anticipated to predominantly support the growth of the studied market. For instance, earlier, INVO Bioscience announced its venture to operate as a fertility clinic in the country. Furthermore, the availability of technologically developed infertility treatment devices is expected further to enhance the demand for infertility treatments and devices. This will ultimately widen the scope and growth of the infertility testing and treatment market across Mexico in the near future. 

On the other hand, Argentina’s infertility testing and treatment market is anticipated to advance at a rapid pace over the forecast period. The major factor supporting this growth is the rising infertility cases, owing to hormonal disorders and substance abuse. As per estimates, a significant amount of the country’s population suffers from PCOS and prostate cancer. Here, some of the treatments for prostate cancer can lead to a decrease in sperm count. This increases the demand for infertility treatments. Furthermore, Argentina emerged as the tourism hotspot for fertility treatment, owing to affordable IVF treatments and high medical services. Hence, as mentioned above, these factors are likely to increase the demand for infertility treatments, boosting the infertility testing and treatment market’s expansion within Argentina. 

COMPETITIVE OUTLOOK 

Some of the enterprises in the infertility testing and treatment market include Endo International Plc, Genea Ltd, Labotect GmbH, Cook Medical Inc, Progyny, Cooper Surgical, and Bangkok IVF Center.